Copertina

Mapping of Functional Metabolic Phenotypes in Acute Myeloid Leukemia

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Sissel Dyrstad, Kimberley Joanne Hatfield, Endre Stigen, Marte Karen Brattås, Karl Johan Tronstad, Håkon Reikvam
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Cancer Medicine
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Gene Expression Profiling in Acute Myeloid Leukemia Patient Subgroups With High and Low Sensitivity Toward SYK Inhibitors
di: Marte Karen Brattås, et al.
Pubblicazione: (2025)

Chidamide in Combination With DCAG With or Without Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia
di: Qingyang Liu, et al.
Pubblicazione: (2025)

Multi‐Omic Analysis Reveals the Impact of Bortezomib in Hyperleukocytic Acute Myeloid Leukemia
di: Jinxian Wu, et al.
Pubblicazione: (2024)

Impact of High Serum Lysozyme Activity on Renal Function and Survival Outcomes in Transplant‐Eligible and Ineligible Acute Myeloid Leukemia
di: Takafumi Tsushima, et al.
Pubblicazione: (2026)

Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients
di: Valentina Salvestrini, et al.
Pubblicazione: (2025)

Clinical Characteristics, Gene Mutation Profiles and Prognosis of Patients With Acute Myeloid Leukemia Carrying PHF6 Mutations
di: Dongmei Wang, et al.
Pubblicazione: (2026)

A Novel Prognostic Risk‐Scoring Model Based on RAS Gene‐Associated Cluster in Pediatric Acute Myeloid Leukemia
di: Cai‐Ju Luo, et al.
Pubblicazione: (2025)

Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: Contrasting viability and growth inhibition in clinically relevant dose and repeated drug cycles
di: Tia R. Tidwell, et al.
Pubblicazione: (2024)

CSF3R Mutations Imply Adverse Prognostic Impact in Adult Acute Myeloid Leukemia Patients: A Single‐Center Retrospective Study
di: Jinjun Yang, et al.
Pubblicazione: (2025)

Racial, Ethnic, and Neighborhood Disparities in Acute Kidney Injury in Pediatric Acute Leukemia
di: Wendy C. Bravo, et al.
Pubblicazione: (2026)

Co‐Mutation of ASXL1 and KRAS Defines a Novel Ultra‐Adverse‐Risk Subtype of Acute Myeloid Leukemia in a Large‐Scale Cohort
di: Yijing Zhao, et al.
Pubblicazione: (2026)

Inflammatory/Immune Adverse Events in Chronic Myeloid Leukemia Patients During Treatment With Bosutinib
di: E. Agostani, et al.
Pubblicazione: (2025)

Clinical Features and T‐Cell Repertoire of Chronic Myeloid Leukemia Patients Who Attempt Discontinuation of Tyrosine Kinase Inhibitors: The ISAC ‐ TFR Study
di: Hiroshi Ureshino, et al.
Pubblicazione: (2025)

Risk Factors Influencing Survival in T‐Cell Lymphoblastic Lymphoma and T‐Cell Acute Lymphoblastic Leukemia
di: Tong Yoon Kim, et al.
Pubblicazione: (2025)

Recent Developments and Evolving Therapeutic Strategies in KMT2A‐Rearranged Acute Leukemia
di: Lei Yin, et al.
Pubblicazione: (2024)

Resilience Development Among Adult Patients With De Novo Acute Leukemia: A Qualitative Study
di: Danyang Li, et al.
Pubblicazione: (2024)

Clinical Impact of Immunoglobulin Heavy Chain Clonality in Pediatric B‐Cell Precursor Acute Lymphoblastic Leukemia
di: Yuta Katai, et al.
Pubblicazione: (2025)

Cerebrospinal Fluid Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study in China
di: Songji Tu, et al.
Pubblicazione: (2024)

Inhibiting H3K27 Demethylases Downregulates CREB ‐ CREBBP , Overcoming Resistance in Relapsed Acute Lymphoblastic Leukemia
di: Juan Lazaro‐Navarro, et al.
Pubblicazione: (2025)

Utility of a Large Series of B‐Cell Precursor Acute Lymphoblastic Leukemia Cell Lines as a Model System
di: Minori Tamai, et al.
Pubblicazione: (2025)

A Multicenter Survival Analysis of Adults Type B‐Acute Lymphoblastic Leukemia in Ecuador. A Retrospective Study of the Real World
di: Brenner Sabando, et al.
Pubblicazione: (2026)

Prevalence of Fms‐Like Tyrosine Kinase 3 (FLT3) Mutations in Patients With Acute Myeloid Leukaemia: A Systematic Literature Review and Meta‐Analysis
di: Juliana F. M. Lewis, et al.
Pubblicazione: (2025)

Correction to “Real‐World Data on Inotuzumab Ozogamicin for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A GRELAL ‐Chile Study”
Pubblicazione: (2025)

Short‐Course Blinatumomab Treatment as a Bridge to Further Salvage Therapy for Relapsed/Refractory B‐Cell Acute Lymphoblastic Leukemia: A Retrospective Single‐Center Study
di: Jin Yin, et al.
Pubblicazione: (2024)

Effect of Statins in the Watch and Wait Phase of Chronic Lymphocytic Leukemia
di: David E. Spaner
Pubblicazione: (2025)

A Novel Modified Bu/Vp16/cy/Flu/Ara‐C Conditioning Regimen Enhances Outcomes for High‐Risk Acute Lymphoblastic Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
di: Xiaoyan Zhao, et al.
Pubblicazione: (2026)

Profiling Ten RHO GTPases in Myeloid Malignancies Reveals Distinct Expression Patterns and Prognostic Associations
di: Beatriz de Almeida Rodrigues, et al.
Pubblicazione: (2026)

Healthcare Resource Utilization and Costs in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Treated With Covalent Bruton's Tyrosine Kinase Inhibitors: Real‐World Impact of Cardiovascular Adverse Events
di: Mavis Obeng‐Kusi, et al.
Pubblicazione: (2025)

Implementing a Genetic Counselor‐Led Model for Hereditary Myeloid Malignancies: A Real‐World Study
di: Madeline VanDerGraaf, et al.
Pubblicazione: (2025)

Cause‐Specific Mortality and Prognostic Impact of Comorbidity in Japanese Patients With Chronic Lymphocytic Leukemia
di: Daisuke Ikeda, et al.
Pubblicazione: (2025)

Feeder Cell Detachment in Drug Response Profiling of Leukemia Cell Coculture Can Be Prevented by Conditioned Medium
di: Ivana Vonkova, et al.
Pubblicazione: (2025)

Machine Learning–Driven Integration of Cancer Cell Phenotypes Predicts Cisplatin Sensitivity
di: Haruki Ujiie, et al.
Pubblicazione: (2025)

Assessment of Treatment Outcome in Chronic Myelogenous Leukemia Patients on Tyrosine Kinase Inhibitors: Insight From a Resource Limited Setting
di: Wude Yewondwosen Awlachew, et al.
Pubblicazione: (2025)

Adverse Effects of Low Serum HDL ‐C Levels on Prognosis and Tumor Immune Microenvironment in Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
di: Weiran Lv, et al.
Pubblicazione: (2026)

Efficacy and Effectiveness Outcomes of Treatments for Double‐Exposed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients: A Systematic Literature Review
di: Mohammed Zuber, et al.
Pubblicazione: (2024)

Advances in the Study of Metabolic Reprogramming in Gastric Cancer
di: Yu Rong, et al.
Pubblicazione: (2025)

The Role of Cholesterol Metabolism and Its Regulation in Tumor Development
di: Yongmei Wu, et al.
Pubblicazione: (2025)

Mutant NPM1 in Acute Myeloid Leukemia Initiation and Maintenance
di: Yanan Jiang, et al.
Pubblicazione: (2026)

Phenotype analysis of families with TP53 germline variants at the Center for Familial Breast and Ovarian Cancer, Cologne
di: K. Kast, et al.
Pubblicazione: (2024)

Gut Microbiota and Hepatocellular Carcinoma: Metabolic Products and Immunotherapy Modulation
di: Kunmin Xiao, et al.
Pubblicazione: (2025)